High interleukin (IL)-12 secretion19, enhanced CD8+ cross-priming activity20, and the capacity to transport intact tumour antigens to lymph nodes (LN)21,22, highlight the importance of CD103+ DCs in the priming of an effective cytotoxic anti-tumour T cell response. This evidence concerns the gene ITGAE and neoplasm.